U
Umesh D. Parashar
Researcher at Centers for Disease Control and Prevention
Publications - 632
Citations - 45080
Umesh D. Parashar is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Rotavirus vaccine. The author has an hindex of 99, co-authored 601 publications receiving 40869 citations. Previous affiliations of Umesh D. Parashar include World Health Organization & National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Importance of On-time RotaTeq Vaccination and Long-term Active Surveillance: In Reply
TL;DR: The comment that “much of the risk of intussusception occurred in patients receiving RotaShield late (eg, first dose at 4 or 6 months)” warrants further clarification.
Journal ArticleDOI
Characteristics of intussusception among children <24 months old before rotavirus vaccine introduction in Lao PDR.
Vannida Douangboupha,Savina Vorasane,Souksavath Sivixay,Chaysavanh Thammavong,Thonglay Vongphacachanh,Vongphet Soulithone,Sanyalack Saysanasongkham,Inthaxay Sisanon,Sousada Narongsack,Soumalay Chankongsine,Sourith Sydasak,Viengpeht Yathotou,L. Franzel-Sassanpour,Umesh D. Parashar,Jacqueline E. Tate,Margaret M. Cortese,Eleanor Burnett +16 more
Journal ArticleDOI
A Comparison of Pathogen Detection and Risk Factors among Symptomatic Children with Gastroenteritis Compared with Asymptomatic Children in the Post-Rotavirus Vaccine Era.
Brian R Lee,Christopher J. Harrison,Ferdaus Hassan,Anjana Sasidharan,Mary E. Moffatt,Kirsten Weltmer,Daniel C. Payne,Mary E Wikswo,Umesh D. Parashar,Rangaraj Selvarangan +9 more
TL;DR: In this paper , the authors describe demographics, pathogen distribution/seasonality, and risk factors in children seeking care for acute gastroenteritis (AGE) at a midwestern US emergency department during 5 post-rotavirus-vaccine years (2011-2016), and further, to compare the same data with matched healthy controls (HC).
Journal ArticleDOI
Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
Xiaoqian Wang,Daniel E. Velasquez Portocarrero,Margaret M. Cortese,Umesh D. Parashar,K. Zaman,Baoming Jiang +5 more
TL;DR: In a clinical trial of Bangladeshi infants who received three doses of RotaTeq (ages 6, 10, and 14) weeks, a head-to-head assessment of two vaccine virus strains to measure rotavirus IgA in sera was conducted as mentioned in this paper .
Journal ArticleDOI
Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.
TL;DR: The results of this work, along with those of the previous paper, confirm the TNC design can be expected to provide reliable estimates of rotavirus VE in both high- and low-income countries.